Attitude of Japanese palliative care specialists towards adjuvant analgesics cancer-related neuropathic pain refractory to opioid therapy: a nationwide cross-sectional survey

Japanese Journal of Clinical Oncology
Hiromichi MatsuokaAtsuko Koyama

Abstract

Cancer-related neuropathic pain (CNP) requires therapy involving multiple pharmaceuticals, including anticonvulsants and antidepressants; however, strong evidence to support this practice is limited. This study is a cross-sectional questionnaire-based survey. As the standard dose of adjuvant analgesics for CNP refractory to opioid therapy is not clear, the purpose of this study is to clarify the opinions of specialists about the usage of duloxetine and pregabalin for patients with CNP refractory to opioid therapy. Two hundred and eight certified palliative care specialists were surveyed and a total of 87 (42%) responses were analyzed. Twenty-five percent of specialists had considered increasing duloxetine doses up to 60 mg/day and 58% had considered increasing pregabalin doses up to 300 mg/day for CNP refractory to opioid therapy. However, 23% of the specialists succeeded in increasing duloxetine doses up to 60 mg/day and 17% in increasing pregabalin doses up to 300 mg/day, respectively.

References

Jul 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Augusto CaraceniFranco De Conno
Nov 4, 2005·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Joel RaskinJoachim F Wernicke
Jul 31, 2007·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Yili L PritchettMichael J Robinson
Apr 21, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·N AttalT Nurmikko
Oct 17, 2012·Pain Practice : the Official Journal of World Institute of Pain·Virginie PianoKris Vissers
Feb 19, 2013·Journal of Pain and Symptom Management·Joost L M JongenKris C Vissers
Apr 4, 2013·JAMA : the Journal of the American Medical Association·Ellen M Lavoie SmithUNKNOWN Alliance for Clinical Trials in Oncology
May 23, 2013·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·John Peter NeySean D Sullivan
Aug 7, 2013·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Michael I BennettMeryem Nimour
Nov 28, 2013·Pain·Matthew R MulveyUNKNOWN IASP Cancer Pain SIG and the EAPC Research Network
Jan 13, 2015·Lancet Neurology·Nanna B FinnerupMark Wallace
Dec 9, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marie FallonBarry J A Laird
Feb 26, 2016·BMJ Supportive & Palliative Care·Christine SandersonDavid C Currow
Mar 23, 2017·The New England Journal of Medicine·Stephanie MathiesonC-W Christine Lin
May 23, 2018·Journal of the National Comprehensive Cancer Network : JNCCN·Robert A Swarm, Maria Dans
Jul 28, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M FallonUNKNOWN ESMO Guidelines Committee
Oct 1, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M FallonUNKNOWN ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved